This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wetzels, R. H. Articles by Ramaekers, F. C. Search for Related Content PubMed PubMed Citation Articles by Wetzels, R. H. Articles by Ramaekers, F. C.

American Journal of Pathology, Vol 138, 751-763, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Basal cell-specific and hyperproliferation-related keratins in human breast cancer

RH Wetzels, HJ Kuijpers, EB Lane, IM Leigh, SM Troyanovsky, R Holland, UJ van Haelst and FC Ramaekers
Department of Pathology, University Hospital, Nijmegen, The Netherlands.

In normal breast tissue and in noninvasive breast carcinomas, various keratin-14 antibodies were reactive predominantly with the basal/myoepithelial cell layer, although mainly in terminal and larger ducts luminal cells sometimes also were stained. A similar reaction pattern was found with an antibody directed against keratin 17, although this antibody was more often found negative than keratin 14 in the pre-existing myoepithelial cells in intraductal carcinomas. Furthermore antibodies reactive with hyperproliferation-related keratins 6 and 16 were used. One of these (LL025) was completely negative in normal breast tissue and noninvasive breast carcinomas. However 10% of the invasive carcinomas were diffusely or focally positive with this latter antibody, while in 18 of 115 cases of invasive breast carcinomas studied, a basal cell phenotype was detected. A relatively high concordance was found between the carcinomas immunostaining with the basal cell and the hyperproliferation-related keratins, but not between these markers and the proliferation marker Ki-67. This supports the conclusion that basal cells in breast cancer may show extensive proliferation, and that absence of Ki-67 staining does not mean that (tumor) cells are not proliferating.

This article has been cited by other articles:

				E. A. Rakha, J. S. Reis-Filho, and I. O. Ellis Basal-Like Breast Cancer: A Critical Review J. Clin. Oncol., May 20, 2008; 26(15): 2568 - 2581. [Abstract] [Full Text] [PDF]

				E Korsching, S S Jeffrey, W Meinerz, T Decker, W Boecker, and H Buerger Basal carcinoma of the breast revisited: an old entity with new interpretations J. Clin. Pathol., May 1, 2008; 61(5): 553 - 560. [Abstract] [Full Text] [PDF]

				L Da Silva, C Clarke, and S R Lakhani Demystifying basal-like breast carcinomas J. Clin. Pathol., December 1, 2007; 60(12): 1328 - 1332. [Abstract] [Full Text] [PDF]

				Y.-J. Chen, Y.-N. Wang, and W.-C. Chang ERK2-mediated C-terminal Serine Phosphorylation of p300 Is Vital to the Regulation of Epidermal Growth Factor-induced Keratin 16 Gene Expression J. Biol. Chem., September 14, 2007; 282(37): 27215 - 27228. [Abstract] [Full Text] [PDF]

				G M K Tse, P-H Tan, P C W Lui, C B Gilks, C S P Poon, T K F Ma, B K B Law, and W W M Lam The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast J. Clin. Pathol., March 1, 2007; 60(3): 315 - 320. [Abstract] [Full Text] [PDF]

				M. Laakso, M. Tanner, J. Nilsson, T. Wiklund, B. Erikstein, P. Kellokumpu-Lehtinen, P. Malmstrom, N. Wilking, J. Bergh, and J. Isola Basoluminal carcinoma: a new biologically and prognostically distinct entity between Basal and luminal breast cancer. Clin. Cancer Res., July 15, 2006; 12(14): 4185 - 4191. [Abstract] [Full Text] [PDF]

				C. Jones, E. Ford, C. Gillett, K. Ryder, S. Merrett, J. S. Reis-Filho, L. G. Fulford, A. Hanby, and S. R. Lakhani Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes Clin. Cancer Res., September 15, 2004; 10(18): 5988 - 5997. [Abstract] [Full Text] [PDF]

				T. O. Nielsen, F. D. Hsu, K. Jensen, M. Cheang, G. Karaca, Z. Hu, T. Hernandez-Boussard, C. Livasy, D. Cowan, L. Dressler, et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Clin. Cancer Res., August 15, 2004; 10(16): 5367 - 5374. [Abstract] [Full Text] [PDF]

				A Kovacs, J Dhillon, and R A Walker Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas Mol. Pathol., December 1, 2003; 56(6): 318 - 322. [Abstract] [Full Text] [PDF]

				Y.-N. Wang and W.-C. Chang Induction of Disease-associated Keratin 16 Gene Expression by Epidermal Growth Factor Is Regulated through Cooperation of Transcription Factors Sp1 and c-Jun J. Biol. Chem., November 14, 2003; 278(46): 45848 - 45857. [Abstract] [Full Text] [PDF]

				B. K. Bloor, N. Tidman, I. M. Leigh, E. Odell, B. Dogan, U. Wollina, L. Ghali, and A. Waseem Expression of Keratin K2e in Cutaneous and Oral Lesions: Association with Keratinocyte Activation, Proliferation, and Keratinization Am. J. Pathol., March 1, 2003; 162(3): 963 - 975. [Abstract] [Full Text] [PDF]

				B. S. Nielsen, F. Rank, J. M. Lopez, M. Balbin, F. Vizoso, L. R. Lund, K. Dano, and C. Lopez-Otin Collagenase-3 Expression in Breast Myofibroblasts as a Molecular Marker of Transition of Ductal Carcinoma in Situ Lesions to Invasive Ductal Carcinomas Cancer Res., October 1, 2001; 61(19): 7091 - 7100. [Abstract] [Full Text] [PDF]

				C. C. Wykoff, N. Beasley, P. H. Watson, L. Campo, S. K. Chia, R. English, J. Pastorek, W. S. Sly, P. Ratcliffe, and A. L. Harris Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast Am. J. Pathol., March 1, 2001; 158(3): 1011 - 1019. [Abstract] [Full Text] [PDF]

				M. Morifuji, S.’i. Taniguchi, H. Sakai, Y. Nakabeppu, and M. Ohishi Differential Expression of Cytokeratin after Orthotopic Implantation of Newly Established Human Tongue Cancer Cell Lines of Defined Metastatic Ability Am. J. Pathol., April 1, 2000; 156(4): 1317 - 1326. [Abstract] [Full Text] [PDF]

				M. J. Smalley, J. Titley, H. Paterson, N. Perusinghe, C. Clarke, and M. J. O'Hare Differentiation of Separated Mouse Mammary Luminal Epithelial and Myoepithelial Cells Cultured on EHS Matrix Analyzed by Indirect Immunofluorescence of Cytoskeletal Antigens J. Histochem. Cytochem., December 1, 1999; 47(12): 1513 - 1524. [Abstract] [Full Text]

				E L Rugg, W H McLean, E B Lane, R Pitera, J R McMillan, P J Dopping-Hepenstal, H A Navsaria, I M Leigh, and R A Eady A functional "knockout" of human keratin 14. Genes & Dev., November 1, 1994; 8(21): 2563 - 2573. [Abstract] [PDF]

				M. Komine, L. S. Rao, T. Kaneko, M. Tomic-Canic, K. Tamaki, I. M. Freedberg, and M. Blumenberg Inflammatory Versus Proliferative Processes in Epidermis. TUMOR NECROSIS FACTOR alpha INDUCES K6b KERATIN SYNTHESIS THROUGH A TRANSCRIPTIONAL COMPLEX CONTAINING NFkappa B AND C/EBPbeta J. Biol. Chem., October 6, 2000; 275(41): 32077 - 32088. [Abstract] [Full Text] [PDF]